Published on in Vol 7, No 12 (2019): December
![Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study](https://asset.jmir.pub/assets/8fe090b04ca4cb5ca4562471b2bc9f5f.png 480w,https://asset.jmir.pub/assets/8fe090b04ca4cb5ca4562471b2bc9f5f.png 960w,https://asset.jmir.pub/assets/8fe090b04ca4cb5ca4562471b2bc9f5f.png 1920w,https://asset.jmir.pub/assets/8fe090b04ca4cb5ca4562471b2bc9f5f.png 2500w)
1 Advanced Biostatistics & Data Analytics Centre of Excellence, R&D Projects Clinical Platforms & Sciences, GlaxoSmithKline, Stevenage, United Kingdom
2 Translational Medicine, Future Pipeline Discovery, GlaxoSmithKline, Stevenage, United Kingdom
3 Clinical Development, AveXis, Bannockburn, IL, United States
4 McLaren Technology Centre, McLaren Applied Technologies, Woking, United Kingdom
5 Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
6 Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King’s College London, London, United Kingdom